Abbott Launches Nutrition Product Manufacturing Facility in Singapore

by Gopalan on  March 02, 2009 at 12:53 PM Corporate News
  •   Print
  •   Share
  •   Comments
  •  Text 
 Abbott Launches Nutrition Product Manufacturing Facility in Singapore
Pharma major Abbott has launched its largest nutrition product manufacturing facility in Singapore to meet increasing regional demand for its pediatric nutrition products.

The facility will serve up to 1 million Asian infants and children each year. This represents the company's growing commitment to the region, its single largest investment in Asia and its largest nutrition investment at US$300 million (S$450 million).

Additionally, Abbott announced an agreement to open a new nutrition science research and development center in Singapore, where its scientists will focus on clinical trials and development of nutrition products tailored to Asian dietary needs. This center of excellence complements Abbott's new pharmaceutical research and development facility, opened last month in Singapore.

"For more than 80 years, Abbott has been a pioneer in nutrition science, bringing the most advanced products to generations of families and children," said Miles D. White, chairman and chief executive officer, Abbott, who dedicated the new plant last week in Singapore. "These new facilities in Singapore will allow us to get even closer to our customers in both proximity and in understanding the unique dietary needs and preferences of Asian consumers."

Abbott's pediatric products sold in Asia, including infant formula, follow-on formula and growing-up milk, are now manufactured in this state-of-the-art facility. This facility offers world-class levels of safety, process control and cleanliness throughout the manufacturing and distribution process.

Products made at Abbott Manufacturing Singapore will continue to contain the same quality ingredients and undergo the same testing standards as Abbott products made elsewhere – consumers will receive the same products they rely on today, a company press release said.

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
News Categories:  
Kidney Health Center

Corporate Related News

» Sun Pharma’s ANDA for Azelastine Nasal Spray Gets FDA Nod » Mylan’s ANDA for Clopidogrel Tablets Gets FDA Approval
» Drug Marketing: Abbott Labs Fined $1.6 Billion » The Cancer Cell Line Encyclopedia Launched by Novartis
» LeGoo Maker Pluromed to be Acquired by Sanofi » NGOs Protest Against Novartis' Glivec Lawsuit in India
» Allscripts Expanding India Operations » Bio-Tech Medicine Proves to be Attractive for TCG Lifesciences
Read More >>